Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population

Physiological Genomics

Volumn 21, Issue , 2005, Pages 212-221

  Orloff, Mohammed S ^a   Iyengar, Sudha K ^a   Winkler, Cheryl A ^b   Goddard, Katrina A B ^a   Dart, Richard A ^c   Ahuja, Tejinder S ^d   Mokrzycki, Michele ^e   Briggs, William A ^f   Korbet, Stephen M ^g   Kimmel, Paul L ^h   Simon, Eric E ⁱ   Trachtman, Howard ^j   Vlahov, David ^k   Michel, Donna M ^l   Berns, Jeffrey S ^m   Smith, Michael C ⁿ   Schelling, Jeffrey R ^o,p   Sedor, John R ^o,p   Kopp, Jeffrey B ^q  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c MARSHFIELD CLINIC   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g RUSH UNIVERSITY MEDICAL CENTER   (United States)

^h GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

ⁱ TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j SCHNEIDER CHILDREN'S HOSPITAL   (United States)

^k NEW YORK ACADEMY OF MEDICINE   (United States)

^l WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m UNIVERSITY OF PENNSYLVANIA   (United States)

ⁿ UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^o CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p Department of Health and Human Services ^*  (United States)

^q NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

more..

Author keywords

African Americans; Polymorphism; Renal failure; Single nucleotide polymorphism haplotype

Indexed keywords

WT1 PROTEIN;

AFRICAN AMERICAN; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; EXON; FEMALE; FOCAL GLOMERULOSCLEROSIS; GENE FREQUENCY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLOMERULOPATHY; HAPLOTYPE; HETEROZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IDIOPATHIC DISEASE; INTRON; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PODOCYTE; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; BIOPSY; DENYS-DRASH SYNDROME; EXONS; FEMALE; FRASIER SYNDROME; GENES, WILMS TUMOR; GENOTYPE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; MALE; MODELS, THEORETICAL; MUTATION; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION; VARIATION (GENETICS);

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 21244487036     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00201.2004     Document Type: Article

References (58)

1. Abecasis GR and Cookson WO. GOLD - graphical overview of linkage disequilibrium. Bioinformatics 16: 182-183, 2000.
2. Baird PN, Santos A, Groves N, Jadresic L, and Cowell JK. Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome. Hum Mol Genet 1: 301-305, 1992.
3. Bakir AA, Bazilinski NG, Rhee HL, Ainis H, and Dunea G. Focal segmental glomerulosclerosis. A common entity in nephrotic black adults. Arch Intern Med 149: 1802-1804, 1989.
4. Barbaux S, Niaudet P, Gubler MC, Grunfeld JP, Jaubert F, Kuttenn F, Fekete CN, Souleyreau-Therville N, Thibaud E, Fellous M, and McElreavey K. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet 17: 467-470, 1997.
5. Bardeesy N, Zabel B, Schmitt K, and Pelletier J. WT1 mutations associated with incomplete Denys-Drash syndrome define a domain predicted to behave in a dominant-negative fashion. Genomics 21: 663-664, 1994.
6. Brenner B, Wildhardt G, Schneider S, and Royer-Pokora B. RNA polymerase chain reaction detects different levels of four alternatively spliced WT1 transcripts in Wilms' tumors. Oncogene 7: 1431-1433, 1992.
7. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, and Housman DE. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60: 509-520, 1990.
8. Campbell CE, Huang A, Gurney AL, Kessler PM, Hewitt JA, and Williams BR. Antisense transcripts and protein binding motifs within the Wilms tumour (WT1) locus. Oncogene 9: 583-595, 1994.
9. Cantor ES, Kimmel PL, and Bosch JP. Effect of race on expression of acquired immunodeficiency syndrome-associated nephropathy. Arch Intern Med 151: 125-128, 1991.
10. Caricasole A, Duarte A, Larsson SH, Hastie ND, Little M, Holmes G, Todorov I, and Ward A. RNA binding by the Wilms tumor suppressor zinc finger proteins. Proc Natl Acad Sci USA 93: 7562-7566, 1996.
11. Cheng R, Ma JZ, Elston RC, and Li MD. Fine mapping functional sites or regions from case-control data using haplotypes of multiple linked SNPs. Ann Hum Genet 69: 102-112, 2005.
12. Cheng R, Ma JZ, Wright FA, Lin S, Gao X, Wang D, Elston RC, and Li MD. Nonparametric disequilibrium mapping of functional sites using haplotypes of multiple tightly linked single-nucleotide polymorphism markers. Genetics 164: 1175-1187, 2003.
13. Clark AG. Inference of haplotypes from PCR-amplified samples of diploid populations. Mol Biol Evol 7: 111-122, 1990.
14. Devlin B and Roeder K. Genomic control for association studies. Biometrics 55: 997-1004, 1999.
15. Eckner R, Ewen ME, Newsome D, Gerdes M, DeCaprio JA, Lawrence JB, and Livingston DM. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev 8: 869-884, 1994.
16. Excoffier L and Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12: 921-927, 1995.
17. Excoffier L and Slatkin M. Incorporating genotypes of relatives into a test of linkage disequilibrium. Am J Hum Genet 62: 171-180, 1998.
18. Fallin D, Cohen A, Essioux L, Chumakov I, Blumenfeld M, Cohen D, and Schork NJ. Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease. Genome Res 11: 143-151, 2001.
19. Fallin D and Schork NJ. Accuracy of haplotype frequency estimation for biallelic loci, via the expectation-maximization algorithm for unphased diploid genotype data. Am J Hum Genet 67: 947-959, 2000.
20. Gessler M, Konig A, and Bruns GA. The genomic organization and expression of the WT1 gene. Genomics 12: 807-813, 1992.
21. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, and Bruns GA. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 343: 774-778, 1990.
22. Grubb GR, Yun K, Williams BR, Eccles MR, and Reeve AE. Expression of WT1 protein in fetal kidneys and Wilms tumors. Lab Invest 71: 472-479, 1994.
23. Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, and Housman DE. Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci USA 88: 9618-9622, 1991.
24. Hammes A, Guo JK, Lutsch G, Leheste JR, Landrock D, Ziegler U, Gubler MC, and Schedl A. Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation. Cell 106: 319-329, 2001.
25. Hawley ME and Kidd KK. HAPLO: a program using the EM algorithm to estimate the frequencies of multi-site haplotypes. J Hered 86: 409-411, 1995.
26. Higgins DG and Sharp PM. Fast and sensitive multiple sequence alignments on a microcomputer. Comput Appl Biosci 5: 151-153, 1989.
27. Hill WG. Estimation of linkage disequilibrium in randomly mating populations. Heredity 33: 229-239, 1974.
28. Huang A, Campbell CE, Bonetta L, McAndrews-Hill MS, Chilton-MacNeill S, Coppes MJ, Law DJ, Feinberg AP, Yeger H, and Williams BR. Tissue, developmental, and tumor-specific expression of divergent transcripts in Wilms tumor. Science 250: 991-994, 1990.
29. Jeanpierre C, Denamur E, Henry I, Cabanis MO, Luce S, Cecille A, Elion J, Peuchmaur M, Loirat C, Niaudet P, Gubler MC, and Junien C. Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database. Am J Hum Genet 62: 824-833, 1998.
30. Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, Tong HQ, Mathis BJ, Rodriguez-Perez JC, Allen PG, Beggs AH, and Pollak MR. Mutations in ACTN4, encoding a-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 24: 251-256, 2000.
31. Kim JM, Wu H, Green G, Winkler CA, Kopp JB, Miner JH, Unanue ER, and Shaw AS. CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 300: 1298-1300, 2003.
32. Kitiyakara C, Kopp JB, and Eggers P. Trends in the epidemiology of focal segmental glomerulosclerosis. Semin Nephrol 23: 172-182, 2003.
33. Kohsaka T, Tagawa M, Takekoshi Y, Yanagisawa H, Tadokoro K, and Yamada M. Exon 9 mutations in the WT1 gene, without influencing KTS splice isoforms, are also responsible for Frasier syndrome. Hum Mutat 14: 466-470, 1999.
34. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, and Jaenisch R. WT-1 is required for early kidney development. Cell 74: 679-691, 1993.
35. Larsson SH, Charlieu JP, Miyagawa K, Engelkamp D, Rassoulzadegan M, Ross A, Cuzin F, van Heyningen V, and Hastie ND. Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 81: 391-401, 1995.
36. Lewontin RC. The interaction of selection and linkage. II. Optimum models. Genetics 50: 757-782, 1964.
37. Loirat C, Andre JL, Champigneulle J, Acquaviva C, Chantereau D, Bourquard R, Elion J, and Denamur E. WT1 splice site mutation in a 46,XX female with minimal-change nephrotic syndrome and Wilms' tumour. Nephrol Dial Transplant 18: 823-825, 2003.
38. Long JC, Williams RC, and Urbanek M. An E-M algorithm and testing strategy for multiple-locus haplotypes. Am J Hum Genet 56: 799-810, 1995.
39. Lundblad JR, Kwok RP, Laurance ME, Harter ML, and Goodman RH. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature 374: 85-88, 1995.
40. Mathis BJ, Kim SH, Calabrese K, Haas M, Seidman JG, Seidman CE, and Pollak MR. A locus for inherited focal segmental glomerulosclerosis maps to chromosome 19q13. Kidney Int 53: 282-286, 1998.
41. 40a. Niksic M, Slight J, Sanford JR, Caceres JF, and Hastie ND. The Wilms' tumour protein (WT1) shuttles between nucleus and cytoplasm and is present in functional polysomes. Hum Mol Genet 13: 463-471, 2004.
42. Patek CE, Fleming S, Miles CG, Bellamy CO, Ladomery M, Spraggon L, Mullins J, Hastie ND, and Hooper ML. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis. Hum Mol Genet 12: 2379-2394, 2003.
43. Patek CE, Little MH, Fleming S, Miles C, Charlieu JP, Clarke AR, Miyagawa K, Christie S, Doig J, Harrison DJ, Porteous DJ, Brookes AJ, Hooper ML, and Hastie ND. A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome. Proc Natl Acad Sci USA 96: 2931-2936, 1999.
44. Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, Fine RN, Silverman BL, and Housman DE. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67: 437-447, 1991.
45. Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, Gosden C, Bard J, Buckler A, Pelletier J, Housman D, Van Heynigen V, and Hastie N. The candidate Wilms' tumour gene is involved in genitourinary development. Nature 346: 194-197, 1990.
46. Rackley RR, Flenniken AM, Kuriyan NP, Kessler PM, Stoler MH, and Williams BR. Expression of the Wilms' tumor suppressor gene WT1 during mouse embryogenesis. Cell Growth Differ 4: 1023-1031, 1993.
47. Rauscher FJ III. The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J 7: 896-903, 1993.
48. Rikitake Y and Moran E. DNA-binding properties of the E1A-associated 300-kilodalton protein. Mol Cell Biol 12: 2826-2836, 1992.
49. Ruf RG, Schultheiss M, Lichtenberger A, Karle SM, Zalewski I, Mucha B, Everding AS, Neuhaus T, Patzer L, Plank C, Haas JP, Ozaltin F, Imm A, Fuchshuber A, Bakkaloglu A, and Hildebrandt F. Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome. Kidney Int 66: 564-570, 2004.
50. Schipper RF, D'Amaro J, de Lange P, Schreuder GM, van Rood JJ, and Oudshoorn M. Validation of haplotype frequency estimation methods. Hum Immunol 59: 518-523, 1998.
51. Shih NY, Li J, Cotran R, Mundel P, Miner JH, and Shaw AS. CD2AP localizes to the slit diaphragm and binds to nephrin via a novel C-terminal domain. Am J Pathol 159: 2303-2308, 2001.
52. Tejani A, Phadke K, Adamson O, Nicastri A, Chen CK, and Sen D. Renal lesions in sickle cell nephropathy in children. Nephron 39: 352-355, 1985.
53. Terwilliger JD and Ott J. A haplotype-based 'haplotype relative risk' approach to detecting allelic associations. Hum Hered 42: 337-346, 1992.
54. Tsukaguchi H, Yager H, Dawborn J, Jost L, Cohlmia J, Abreu PF, Pereira AB, and Pollak MR. A locus for adolescent and adult onset familial focal segmental glomerulosclerosis on chromosome 1q25-31. J Am Soc Nephrol 11: 1674-1680, 2000.
55. Wagner KD, Wagner N, and Schedl A. The complex life of WT1. J Cell Sci 116: 1653-1658, 2003.
56. Winn MP, Conlon PJ, Lynn KL, Howell DN, Gross DA, Rogala AR, Smith AH, Graham FL, Bembe M, Quarles LD, Pericak-Vance MA, and Vance JM. Clinical and genetic heterogeneity in familial focal segmental glomerulosclerosis. International Collaborative Group for the Study of Familial Focal Segmental Glomerulosclerosis. Kidney Int 55: 1241-1246, 1999.
57. Yaciuk P and Moran E. Analysis with specific polyclonal antiserum indicates that the E1A-associated 300-kDa product is a stable nuclear phosphoprotein that undergoes cell cycle phase-specific modification. Mol Cell Biol 11: 5389-5397, 1991.
58. Yeger H, Cullinane C, Flenniken A, Chilton-MacNeil S, Campbell C, Huang A, Bonetta L, Coppes MJ, Thorner P, and Williams BR. Coordinate expression of Wilms' tumor genes ,correlates with Wilms' tumor phenotypes. Cell Growth Differ 3: 855-864, 1992.